•  
  •  
 

Abstract

A unique of synthetic methods was employed to prepare 2-(4-methoxyphenyl)-4-phenyl-1,10-phenanthroline (5) derivatives from 4-methoxy-benzaldehyde (1), acetophenone (2), and 8-aminoquinoline (4) with aldol condensation and cyclization reactions. The derivatives were tested through antiplasmodial test. The synthesis of derivatives compound 5 was conducted in three steps. The 3-(4-methoxyphenyl)-1-phenylpropenone 3 was synthesized through aldol condensation of 1 and 2 which has a yield of 96.42%. The compound 5 was synthesized through cyclization of compound 4 and 3 with 84.55% yield. The derivative of compound 5 was synthesized from compound 5 using DMS and DES reagents which refluxed for 21 and 22 h, to produce (1)-N-methyl-9-(4-methoxyphenyl)-7-phenyl-1,10- phenanthrolinium sulfate (6) and (1)-N-ethyl-9-(4-methoxyphenyl)-7-phenyl-1,10-phenanthrolinium sulfate (7) with 91.42 and 86.36% yields, respectively. Results of in vitro testing of antiplasmodial activity of compound 5 derivatives (i.e., compound 6 and 7) against chloroquine-resistant P. falciparum FCR3 strain showed that compound 7 had higher antimalarial activity than compounds 5 and 6. Whereas, results of in vitro testing against chloroquine-sensitive P. falciparum D10 strain showed that compound 6 has higher antimalarial activity than compounds 5 and 7.

References

[1] D.A. Fidock. P.J. Rosenthal, S.L. Croft, R. Brun, S. Nwaka, Nature Rev. 3 (2004) 509. [2] J.P. Daily, J. Clin Pharmacol. 46 (2006) 1487. [3] U. Tatuk, S. Jain, P.P. Priya, J. Biosci. 30/5 (2005) 567. [4] N. Mahmoudi, J.V.J. Ortiz, L. Ciceron, J. Galvez, D. Mazier, M. Danis, F. Derouin, R.G. Domenech, J. Antimicrob. Chemo. 57 (2006) 489. [5] WHO, World Health Organization, Malaria Unit, Global Malaria Control. Bull. WHO 71 (2009) 281. [6] J.S. Kayembe, K.M. Taba, K. Ntumba, M.T.C. Tshiongo, T.K. Kazadi, J. Med. Plant. Res., 4/11 (2010) 991. [7] G.J. Crowthe, A.J. Napuli, J.H. Gilligan, K. Gagaring, R. Borboa, C. Francek, Z. Chen, E.F. Dagostino, J.B. Stockmyer, Y. Wang, P.P. Rodenbough, L.J. Castaneda, D.J. Leibly, J. Bhandari, M.H. Gelb, A. Brinker, I. H. Engels, J. Taylor, A.K. Chatterjee, P. Fantauzzi, R.J. Glynne, W.C.V. Voorhis, K. L. Kuhen, Molec. Biochem. Parasitol. 175 (2011) 21. [8] A. Fernández, C. Valdés, Open Med Chem J. 5 (2011) 11. [9] P. Olumese, Acta Tropica. 95 (2005) 265. [10] Nuri, Y.P. Dachlan, M.H. Santosa, N.C. Zaini, A. Widyawaruyanti, Sjafruddin, Majalah Farmasi Airlangga 5/3 (2005) 88. [11] M.A.Wijayanti, E.N. Solikhah, I. Tahir, R. Hadanu, Jumina, Supargiono, Mustofa, J. Health Sci. 52/6 (2006) 794. [12] R. Hadanu, S. Mastjeh, Jumina, Mustofa, M.A. Wijayanti, E.N. Sholikhah, Indones. J. Chem. 2/7 (2007) 197. [13] A.D. Yapi, Mustofa, A. Valentin, O. Chavignon, J. Teulade, M. Mallie, J. Chapat, Y. Blace, Chem. Pharm. Bull. 48 (2000) 1886. [14] A.D. Yapi, A. Valentin, J.M. Chezal, O. Chavignon, B. Chaillot, R. Gerhardt, J.C. Teulade, Y. Blace, Arch. Pharm. Chem. Life Sci. 339 (2006) 201. [15] M. Mustofa, A.D. Yapi, A. Valentin, I. Tahir, Bul. I. Ked. 35 (2003) 67. [16] M.A. Wijayanti, E.N. Sholikhah, R. Hadanu, Jumina, Supargiyono, Mustofa, Malaria Res. Treatment, Article ID 540786 (2010) 1. [17] W. Trager, J.B. Jensen, Science, 193/4254 (1976) 673. [18] C. Lambros, J.P. Vanderberg, J. Parasitol. 65 (1979) 418. [19] R.E. Desjardin, C.J. Canfield, J.D. Haynes, J.D. Chulay, Antimicrob. Agents Chemother. 16 (1979) 710. [20] E.N. Solikhah, Supargiono, Jumina, M.A. Wijayanti, I. Tahir, R. Hadanu, Mustofa, J. Pharmacol. 13 (2006) 831.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.